Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study

Benzer Materyaller

• Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial
  Yazar:: Yatham, Lakshmi N., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies
  Yazar:: McIntyre, Roger S., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Efficacy of cariprazine in bipolar I depression across patient characteristics: a post hoc analysis of pooled randomized, placebo-controlled studies
  Yazar:: Patel, Mehul, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
  Yazar:: Earley, Willie R., ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial
  Yazar:: Fava, Maurizio, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)